AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA
Authors: Orr, N Galen, JE Levine, MM
Citation: N. Orr et al., Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA, VACCINE, 19(13-14), 2001, pp. 1694-1700
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915
Authors: Wang, JY Pasetti, MF Noriega, FR Anderson, RJ Wasserman, SS Galen, JE Sztein, MB Levine, MM
Citation: Jy. Wang et al., Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915, INFEC IMMUN, 69(8), 2001, pp. 4734-4741
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosalvaccine against Shigella and ETEC infection
Authors: Altboum, Z Barry, EM Losonsky, G Galen, JE Levine, MM
Citation: Z. Altboum et al., Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosalvaccine against Shigella and ETEC infection, INFEC IMMUN, 69(5), 2001, pp. 3150-3158
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR
Authors: Cooper, PJ Chico, M Sandoval, C Espinel, I Guevara, A Levine, MM Griffin, GE Nutman, TB
Citation: Pj. Cooper et al., Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR, INFEC IMMUN, 69(3), 2001, pp. 1574-1580
Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains
Authors: Gomez-Duarte, OG Pasetti, MF Santiago, A Sztein, MB Hoffman, SL Levine, MM
Citation: Og. Gomez-duarte et al., Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains, INFEC IMMUN, 69(2), 2001, pp. 1192-1198
Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
Authors: Tacket, CO Galen, J Sztein, MB Losonsky, G Wyant, TL Nataro, J Wasserman, SS Edelman, R Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C, CLIN IMMUNO, 97(2), 2000, pp. 146-153
Immunization against bacterial diseases of the intestine
Authors: Levine, MM
Citation: Mm. Levine, Immunization against bacterial diseases of the intestine, J PED GASTR, 31(4), 2000, pp. 336-355
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections
Authors: Plaisance, KI Kudaravalli, S Wasserman, SS Levine, MM Mackowiak, PA
Citation: Ki. Plaisance et al., Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections, PHARMACOTHE, 20(12), 2000, pp. 1417-1422
A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model
Authors: Pasetti, MF Pickett, TE Levine, MM Sztein, MB
Citation: Mf. Pasetti et al., A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model, VACCINE, 18(28), 2000, pp. 3208-3213
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
Authors: Richie, E Punjabi, NH Sidharta, Y Peetosutan, K Sukandar, M Wasserman, SS Lesmana, M Wangsasaputra, F Pandam, S Levine, MM O'Hanley, P Cryz, SJ Simanjuntak, CH
Citation: E. Richie et al., Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area, VACCINE, 18(22), 2000, pp. 2399-2410
Delta guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin
Authors: Anderson, RJ Pasetti, MF Sztein, MB Levine, MM Noriega, FR
Citation: Rj. Anderson et al., Delta guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin, VACCINE, 18(21), 2000, pp. 2193-2202
Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C
Authors: Wu, SG Beier, M Sztein, MB Galen, J Pickett, T Holder, AA Gomez-Duarte, OG Levine, MM
Citation: Sg. Wu et al., Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C, J BIOTECH, 83(1-2), 2000, pp. 125-135
Albendazole treatment of children with ascariasis enhances the vibriocidalantibody response to the live attenuated oral cholera vaccine CVD 103-HgR
Authors: Cooper, PJ Chico, ME Losonsky, G Sandoval, C Espinel, I Sridhara, R Aguilar, M Guevara, A Guderian, RH Levine, MM Griffin, GE Nutman, TB
Citation: Pj. Cooper et al., Albendazole treatment of children with ascariasis enhances the vibriocidalantibody response to the live attenuated oral cholera vaccine CVD 103-HgR, J INFEC DIS, 182(4), 2000, pp. 1199-1206
Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
Authors: Tacket, CO Mason, HS Losonsky, G Estes, MK Levine, MM Arntzen, CJ
Citation: Co. Tacket et al., Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes, J INFEC DIS, 182(1), 2000, pp. 302-305
Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000)
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000), J IMMUNOL, 165(8), 2000, pp. 4756-4756
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain, J IMMUNOL, 164(4), 2000, pp. 2221-2232
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli
Authors: Koprowski, H Levine, MM Anderson, RJ Losonsky, G Pizza, M Barry, EM
Citation: H. Koprowski et al., Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli, INFEC IMMUN, 68(9), 2000, pp. 4884-4892
Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909
Authors: Wang, JY Noriega, FR Galen, JE Barry, E Levine, MM
Citation: Jy. Wang et al., Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909, INFEC IMMUN, 68(8), 2000, pp. 4647-4652
Role of EspB in experimental human enteropathogenic Escherichia coli infection
Authors: Tacket, CO Sztein, MB Losonsky, G Abe, A Finlay, BB McNamara, BP Fantry, GT James, SP Nataro, JP Levine, MM Donnenberg, MS
Citation: Co. Tacket et al., Role of EspB in experimental human enteropathogenic Escherichia coli infection, INFEC IMMUN, 68(6), 2000, pp. 3689-3695
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans
Authors: Kotloff, KL Noriega, FR Samandari, T Sztein, MB Losonsky, GA Nataro, JP Picking, WD Barry, EM Levine, MM
Citation: Kl. Kotloff et al., Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans, INFEC IMMUN, 68(3), 2000, pp. 1034-1039
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors
Authors: Pickett, TE Pasetti, MF Galen, JE Sztein, MB Levine, MM
Citation: Te. Pickett et al., In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors, INFEC IMMUN, 68(1), 2000, pp. 205-213
Shigella, Salmonella typhi, and Escherichia coli: Effects of microbes on the immune system
Authors: Levine, MM Sztein, MB
Citation: Mm. Levine et Mb. Sztein, Shigella, Salmonella typhi, and Escherichia coli: Effects of microbes on the immune system, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, 2000, pp. 171-194
In memoriam - HIV vaccines and prevention in a world without Mary Lou Clements-Mann and Jonathan Mann
Authors: Levine, MM Curran, J
Citation: Mm. Levine et J. Curran, In memoriam - HIV vaccines and prevention in a world without Mary Lou Clements-Mann and Jonathan Mann, J ACQ IMM D, 20(3), 1999, pp. 318-320
Attenuated Delta guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses
Authors: Pasetti, MF Anderson, RJ Noriega, FR Levine, MM Sztein, MB
Citation: Mf. Pasetti et al., Attenuated Delta guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses, CLIN IMMUNO, 92(1), 1999, pp. 76-89
Risultati: 1-25 | 26-47